A HARTLEPOOL company is creating the latest jobs boost on an enterprise zone.
Hartlepool-based Hart Biologicals, which makes specialist medical devices to investigate the blood clotting function in patients, will create 13 new jobs including scientists specialising in research and development.
They are being created as part of the company’s expansion plans at Hartlepool’s Rivergreen Business Centre within Queens Meadow Business Park, and brings the total number of jobs created at Queens Meadow to more than 150 since it was granted Enterprise Zone status over two years ago.
The award-winning firm has taken over a 6,500 sq ft unit next to its headquarters which will house its research and development team.
Managing director Alby Pattison said: “This expansion is in response to demands, and we are delighted to have been able to take over the unit next door to our base.”
Queens Meadow Business Park is one of eight key sites identified in the Hartlepool Vision – Hartlepool Council’s blueprint to spark regeneration, create jobs and ensure the future prosperity for the town.
Coun Kevin Cranney, vice-chair of Regeneration Services Committee, said: “Hart Biologicals has gone from strength to strength since it was formed in Hartlepool in 2003.
“The Enterprise Zones offer tremendous incentives to companies and I’m delighted that Hart Biologicals is expanding in Hartlepool and creating an extra 13 jobs on top of the 23 existing jobs.”
Hart Biologicals has had support from Hartlepool Council, Tees Valley Unlimited, UK Steel Enterprise, the North East Chamber of Commerce and UKTI to bring its expansion plan to fruition.